Hamilton Thorne (TSX:HTL) Buyback Yield % : 0.00 (As of Jun. 01, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Hamilton Thorne Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Hamilton Thorne's current buyback yield was 0.00%.

Hamilton Thorne Buyback Yield % Historical Data

The historical data trend for Hamilton Thorne's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamilton Thorne Buyback Yield % Chart

Hamilton Thorne Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buyback Yield %

Get a 7-Day Free Trial

-3.23

Hamilton Thorne Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Buyback Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Hamilton Thorne's Buyback Yield %

For the Medical Devices subindustry, Hamilton Thorne's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hamilton Thorne's Buyback Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hamilton Thorne's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Hamilton Thorne's Buyback Yield % falls into.

Hamilton Thorne Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Hamilton Thorne's Buyback Yield for the fiscal year that ended in Dec. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	0)	/	202.32625
	=	0.00%

Hamilton Thorne's annualized Buyback Yield for the quarter that ended in Mar. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (0	+	0)	*	4	/	198.9871
	=	0.00%

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Mar. 2024) data.

Hamilton Thorne Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Hamilton Thorne's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hamilton Thorne (TSX:HTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hamilton Thorne Ltd (TSX:HTL) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

HTLZF:USA 0ZM:Germany

Address

100 Cummings Center, Suite 465E, Beverly, MA, USA, 01915

Website

https://www.hamiltonthorne.ltd

Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.

Executives

Robert J Potter

Director

Hamilton Thorne (TSX:HTL) Headlines

No Headlines